99%+ Purity Trazodone Hydrochloride (Trazodone Hcl) CAS :25332-39-2
Product Summary:
| Trazodone hydrochloride is indicated for the treatment of depression. The efficacy of trazodone hydrochloride has been demonstrated in both inpatient and outpatient settings and for depressed patients with and without prominent anxiety. The depressive illness of patients studied corresponds to the Major Depressive Episode criteria of the American Psychiatric Association's Diagnostic and Statistical Manual, III1. |
99%+ Purity Trazodone Hydrochloride (Trazodone Hcl) CAS :25332-39-2
Trazodone Hydrochloride Details:
Product name:Trazodone hydrochloride
Other name:2-chloro-3-pyridino
CAS register number:25332-39-2
EINECS:246-855-5
Molecular formula:C19H23Cl2N5O
Molecular weight:408.32
Appearance:White Powder
Melting point:223-226°C
Assay:99%
Package:foil bag,25kg/drum
Trazodone Hydrochloride Specification:
COA
Test | Analysis Standard | Results |
Appearance | white or almost white crystalline powder | Conform |
Assay | ≥99% | 99.53% |
Melting point | 223-226°C | 223.7-224.5°C |
Loss On Drying | ≤0.5% | 0.22% |
Trazodone Hydrochloride Description:
Trazodone hydrochloride is indicated for the treatment of depression. The efficacy of trazodone hydrochloride has been demonstrated in both inpatient and outpatient settings and for depressed patients with and without prominent anxiety. The depressive illness of patients studied corresponds to the Major Depressive Episode criteria of the American Psychiatric Association's Diagnostic and Statistical Manual, III1.
Trazodone Hydrochloride Application:
Major Depressive Episode implies a prominent and relatively persistent (nearly every day for at least two weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least four of the following eight symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigability, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and suicidal ideation or attempts.
